nodes	percent_of_prediction	percent_of_DWPC	metapath
Lamivudine—ABCC3—Etoposide—brain cancer	0.141	0.273	CbGbCtD
Lamivudine—ABCC1—Etoposide—brain cancer	0.0863	0.168	CbGbCtD
Lamivudine—ABCC2—Carboplatin—brain cancer	0.0761	0.148	CbGbCtD
Lamivudine—ABCG2—Carboplatin—brain cancer	0.0688	0.134	CbGbCtD
Lamivudine—ABCC2—Etoposide—brain cancer	0.0639	0.124	CbGbCtD
Lamivudine—ABCG2—Etoposide—brain cancer	0.0577	0.112	CbGbCtD
Lamivudine—ABCB1—Etoposide—brain cancer	0.0208	0.0405	CbGbCtD
Lamivudine—PGK1—hindbrain—brain cancer	0.00883	0.0555	CbGeAlD
Lamivudine—NME2—pineal body—brain cancer	0.0081	0.0509	CbGeAlD
Lamivudine—Decitabine—DNMT1—brain cancer	0.00557	0.737	CrCbGaD
Lamivudine—PGK1—brainstem—brain cancer	0.00506	0.0318	CbGeAlD
Lamivudine—CMPK1—hindbrain—brain cancer	0.00451	0.0283	CbGeAlD
Lamivudine—NME2—hindbrain—brain cancer	0.00441	0.0277	CbGeAlD
Lamivudine—PCYT2—gonad—brain cancer	0.00436	0.0274	CbGeAlD
Lamivudine—PGK1—gonad—brain cancer	0.00375	0.0235	CbGeAlD
Lamivudine—PCYT2—endocrine gland—brain cancer	0.0033	0.0207	CbGeAlD
Lamivudine—PCYT2—head—brain cancer	0.00326	0.0205	CbGeAlD
Lamivudine—NT5C—pituitary gland—brain cancer	0.00309	0.0194	CbGeAlD
Lamivudine—PCYT2—central nervous system—brain cancer	0.00297	0.0187	CbGeAlD
Lamivudine—PCYT1A—gonad—brain cancer	0.00297	0.0187	CbGeAlD
Lamivudine—PGK1—endocrine gland—brain cancer	0.00283	0.0178	CbGeAlD
Lamivudine—PGK1—head—brain cancer	0.0028	0.0176	CbGeAlD
Lamivudine—CMPK1—brainstem—brain cancer	0.00258	0.0162	CbGeAlD
Lamivudine—NME1-NME2—endocrine gland—brain cancer	0.00258	0.0162	CbGeAlD
Lamivudine—PGK1—central nervous system—brain cancer	0.00255	0.016	CbGeAlD
Lamivudine—NME1-NME2—head—brain cancer	0.00255	0.016	CbGeAlD
Lamivudine—NME2—brainstem—brain cancer	0.00253	0.0159	CbGeAlD
Lamivudine—SLC22A1—ganglion—brain cancer	0.00252	0.0159	CbGeAlD
Lamivudine—PGK1—cerebellum—brain cancer	0.0025	0.0157	CbGeAlD
Lamivudine—NT5C—endocrine gland—brain cancer	0.00239	0.015	CbGeAlD
Lamivudine—NT5C—head—brain cancer	0.00236	0.0148	CbGeAlD
Lamivudine—PCYT2—brain—brain cancer	0.00236	0.0148	CbGeAlD
Lamivudine—CMPK1—telencephalon—brain cancer	0.00229	0.0144	CbGeAlD
Lamivudine—PCYT1A—endocrine gland—brain cancer	0.00224	0.0141	CbGeAlD
Lamivudine—PCYT1A—head—brain cancer	0.00222	0.0139	CbGeAlD
Lamivudine—NT5C—central nervous system—brain cancer	0.00216	0.0135	CbGeAlD
Lamivudine—NT5C—cerebellum—brain cancer	0.00211	0.0132	CbGeAlD
Lamivudine—PGK1—brain—brain cancer	0.00203	0.0127	CbGeAlD
Lamivudine—PCYT1A—central nervous system—brain cancer	0.00202	0.0127	CbGeAlD
Lamivudine—Zalcitabine—CYP2C9—brain cancer	0.00198	0.263	CrCbGaD
Lamivudine—CMPK1—gonad—brain cancer	0.00191	0.012	CbGeAlD
Lamivudine—CMPK1—pituitary gland—brain cancer	0.00187	0.0117	CbGeAlD
Lamivudine—NT5C—brain—brain cancer	0.00171	0.0108	CbGeAlD
Lamivudine—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00168	0.0166	CbGpPWpGaD
Lamivudine—CMPK1—midbrain—brain cancer	0.00165	0.0103	CbGeAlD
Lamivudine—CMPK1—spinal cord—brain cancer	0.00161	0.0101	CbGeAlD
Lamivudine—PCYT1A—brain—brain cancer	0.00161	0.0101	CbGeAlD
Lamivudine—ABCC4—Ectoderm Differentiation—TSC22D1—brain cancer	0.00156	0.0155	CbGpPWpGaD
Lamivudine—NME1—endocrine gland—brain cancer	0.0015	0.00943	CbGeAlD
Lamivudine—NME1—head—brain cancer	0.00148	0.00931	CbGeAlD
Lamivudine—CMPK1—endocrine gland—brain cancer	0.00145	0.00909	CbGeAlD
Lamivudine—CMPK1—head—brain cancer	0.00143	0.00897	CbGeAlD
Lamivudine—NME2—endocrine gland—brain cancer	0.00141	0.00888	CbGeAlD
Lamivudine—ABCC2—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.0014	0.0139	CbGpPWpGaD
Lamivudine—NME2—head—brain cancer	0.0014	0.00877	CbGeAlD
Lamivudine—NME1—central nervous system—brain cancer	0.00135	0.0085	CbGeAlD
Lamivudine—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00134	0.0132	CbGpPWpGaD
Lamivudine—NME1—cerebellum—brain cancer	0.00132	0.00831	CbGeAlD
Lamivudine—CMPK1—central nervous system—brain cancer	0.0013	0.00819	CbGeAlD
Lamivudine—CMPK1—cerebellum—brain cancer	0.00127	0.008	CbGeAlD
Lamivudine—NME2—central nervous system—brain cancer	0.00127	0.008	CbGeAlD
Lamivudine—NME2—cerebellum—brain cancer	0.00125	0.00782	CbGeAlD
Lamivudine—NME1—Regulation of CDC42 activity—APC—brain cancer	0.00124	0.0123	CbGpPWpGaD
Lamivudine—DCK—telencephalon—brain cancer	0.00114	0.00717	CbGeAlD
Lamivudine—NME1—brain—brain cancer	0.00107	0.00675	CbGeAlD
Lamivudine—PGK1—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.00104	0.0103	CbGpPWpGaD
Lamivudine—CMPK1—brain—brain cancer	0.00103	0.0065	CbGeAlD
Lamivudine—NME2—brain—brain cancer	0.00101	0.00635	CbGeAlD
Lamivudine—SLC22A1—telencephalon—brain cancer	0.000974	0.00612	CbGeAlD
Lamivudine—ABCC1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000969	0.00958	CbGpPWpGaD
Lamivudine—DCK—gonad—brain cancer	0.000953	0.00599	CbGeAlD
Lamivudine—DCK—pituitary gland—brain cancer	0.00093	0.00584	CbGeAlD
Lamivudine—DCK—medulla oblongata—brain cancer	0.000897	0.00564	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000845	0.00836	CbGpPWpGaD
Lamivudine—DCK—midbrain—brain cancer	0.00082	0.00515	CbGeAlD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.000801	0.00792	CbGpPWpGaD
Lamivudine—DCK—spinal cord—brain cancer	0.0008	0.00503	CbGeAlD
Lamivudine—SLC22A3—gonad—brain cancer	0.000777	0.00488	CbGeAlD
Lamivudine—ABCC1—telencephalon—brain cancer	0.00077	0.00483	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00075	0.00741	CbGpPWpGaD
Lamivudine—PGK1—Carbohydrate metabolism—ENO2—brain cancer	0.000748	0.00739	CbGpPWpGaD
Lamivudine—NME1—E-cadherin signaling in the nascent adherens junction—CCND1—brain cancer	0.000735	0.00727	CbGpPWpGaD
Lamivudine—NME1—E-cadherin signaling in the nascent adherens junction—CTNNB1—brain cancer	0.000728	0.0072	CbGpPWpGaD
Lamivudine—DCK—endocrine gland—brain cancer	0.00072	0.00452	CbGeAlD
Lamivudine—ABCC2—Irinotecan Pathway—APC—brain cancer	0.00072	0.00712	CbGpPWpGaD
Lamivudine—ABCC1—Irinotecan Pathway—APC—brain cancer	0.000711	0.00703	CbGpPWpGaD
Lamivudine—DCK—head—brain cancer	0.000711	0.00447	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000705	0.00697	CbGpPWpGaD
Lamivudine—PCYT2—Phospholipid metabolism—PIK3CG—brain cancer	0.000696	0.00688	CbGpPWpGaD
Lamivudine—ABCC3—endocrine gland—brain cancer	0.00069	0.00433	CbGeAlD
Lamivudine—ABCC3—head—brain cancer	0.000681	0.00428	CbGeAlD
Lamivudine—SLC22A6—brain—brain cancer	0.000675	0.00424	CbGeAlD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000668	0.00661	CbGpPWpGaD
Lamivudine—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000659	0.00652	CbGpPWpGaD
Lamivudine—DCK—central nervous system—brain cancer	0.000649	0.00408	CbGeAlD
Lamivudine—ABCB1—blood vessel—brain cancer	0.000648	0.00407	CbGeAlD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000641	0.00633	CbGpPWpGaD
Lamivudine—ABCG2—telencephalon—brain cancer	0.000637	0.004	CbGeAlD
Lamivudine—DCK—cerebellum—brain cancer	0.000634	0.00399	CbGeAlD
Lamivudine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000628	0.00621	CbGpPWpGaD
Lamivudine—ABCC1—pituitary gland—brain cancer	0.000627	0.00394	CbGeAlD
Lamivudine—ABCG2—Irinotecan Pathway—APC—brain cancer	0.000626	0.00619	CbGpPWpGaD
Lamivudine—ABCC3—central nervous system—brain cancer	0.000621	0.0039	CbGeAlD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000618	0.00611	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000615	0.00608	CbGpPWpGaD
Lamivudine—SLC22A1—endocrine gland—brain cancer	0.000614	0.00386	CbGeAlD
Lamivudine—PGK1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000612	0.00605	CbGpPWpGaD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—CDK4—brain cancer	0.000607	0.006	CbGpPWpGaD
Lamivudine—SLC22A1—head—brain cancer	0.000606	0.00381	CbGeAlD
Lamivudine—Vomiting—Lomustine—brain cancer	0.000598	0.00274	CcSEcCtD
Lamivudine—Oedema—Procarbazine—brain cancer	0.000597	0.00274	CcSEcCtD
Lamivudine—Dysuria—Temozolomide—brain cancer	0.000594	0.00272	CcSEcCtD
Lamivudine—Neutropenia—Temozolomide—brain cancer	0.000594	0.00272	CcSEcCtD
Lamivudine—Infection—Procarbazine—brain cancer	0.000593	0.00272	CcSEcCtD
Lamivudine—Hyperglycaemia—Carmustine—brain cancer	0.000593	0.00272	CcSEcCtD
Lamivudine—NME1—Arf6 trafficking events—CTNNB1—brain cancer	0.000588	0.00581	CbGpPWpGaD
Lamivudine—Shock—Procarbazine—brain cancer	0.000588	0.00269	CcSEcCtD
Lamivudine—SLC22A3—endocrine gland—brain cancer	0.000587	0.00369	CbGeAlD
Lamivudine—Pollakiuria—Temozolomide—brain cancer	0.000587	0.00269	CcSEcCtD
Lamivudine—Thrombocytopenia—Procarbazine—brain cancer	0.000585	0.00268	CcSEcCtD
Lamivudine—Depression—Carmustine—brain cancer	0.000584	0.00268	CcSEcCtD
Lamivudine—Chills—Hydroxyurea—brain cancer	0.000584	0.00268	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000583	0.00576	CbGpPWpGaD
Lamivudine—SLC22A3—head—brain cancer	0.00058	0.00364	CbGeAlD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—brain cancer	0.000578	0.00572	CbGpPWpGaD
Lamivudine—Hyperhidrosis—Procarbazine—brain cancer	0.000577	0.00265	CcSEcCtD
Lamivudine—Renal failure—Carmustine—brain cancer	0.000576	0.00264	CcSEcCtD
Lamivudine—Alopecia—Hydroxyurea—brain cancer	0.000575	0.00264	CcSEcCtD
Lamivudine—Neuropathy peripheral—Carmustine—brain cancer	0.000574	0.00263	CcSEcCtD
Lamivudine—Hyperglycaemia—Temozolomide—brain cancer	0.000573	0.00263	CcSEcCtD
Lamivudine—Stomatitis—Carmustine—brain cancer	0.000571	0.00262	CcSEcCtD
Lamivudine—ABCC4—endocrine gland—brain cancer	0.000569	0.00358	CbGeAlD
Lamivudine—Anorexia—Procarbazine—brain cancer	0.000569	0.00261	CcSEcCtD
Lamivudine—Erythema—Hydroxyurea—brain cancer	0.000566	0.0026	CcSEcCtD
Lamivudine—Depression—Temozolomide—brain cancer	0.000564	0.00259	CcSEcCtD
Lamivudine—ABCC4—head—brain cancer	0.000562	0.00353	CbGeAlD
Lamivudine—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000561	0.00257	CcSEcCtD
Lamivudine—Nausea—Lomustine—brain cancer	0.000559	0.00256	CcSEcCtD
Lamivudine—Hypotension—Procarbazine—brain cancer	0.000558	0.00256	CcSEcCtD
Lamivudine—Neuropathy peripheral—Temozolomide—brain cancer	0.000555	0.00254	CcSEcCtD
Lamivudine—SLC22A1—central nervous system—brain cancer	0.000554	0.00348	CbGeAlD
Lamivudine—Stomatitis—Temozolomide—brain cancer	0.000552	0.00253	CcSEcCtD
Lamivudine—ABCC2—endocrine gland—brain cancer	0.000551	0.00346	CbGeAlD
Lamivudine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000544	0.00249	CcSEcCtD
Lamivudine—PGK1—Disease—DTX2—brain cancer	0.000542	0.00536	CbGpPWpGaD
Lamivudine—Insomnia—Procarbazine—brain cancer	0.00054	0.00248	CcSEcCtD
Lamivudine—Paraesthesia—Procarbazine—brain cancer	0.000536	0.00246	CcSEcCtD
Lamivudine—Hepatobiliary disease—Temozolomide—brain cancer	0.000535	0.00245	CcSEcCtD
Lamivudine—Sinusitis—Temozolomide—brain cancer	0.000531	0.00243	CcSEcCtD
Lamivudine—Somnolence—Procarbazine—brain cancer	0.000531	0.00243	CcSEcCtD
Lamivudine—Cramp muscle—Etoposide—brain cancer	0.000529	0.00243	CcSEcCtD
Lamivudine—SLC22A3—central nervous system—brain cancer	0.000529	0.00332	CbGeAlD
Lamivudine—PCYT1A—Phospholipid metabolism—PIK3CG—brain cancer	0.000528	0.00522	CbGpPWpGaD
Lamivudine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000525	0.00241	CcSEcCtD
Lamivudine—Anaemia—Hydroxyurea—brain cancer	0.000523	0.0024	CcSEcCtD
Lamivudine—Hypoaesthesia—Carmustine—brain cancer	0.000523	0.0024	CcSEcCtD
Lamivudine—Decreased appetite—Procarbazine—brain cancer	0.000519	0.00238	CcSEcCtD
Lamivudine—ABCG2—pituitary gland—brain cancer	0.000519	0.00326	CbGeAlD
Lamivudine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000518	0.00238	CcSEcCtD
Lamivudine—Connective tissue disorder—Carmustine—brain cancer	0.000517	0.00237	CcSEcCtD
Lamivudine—DCK—brain—brain cancer	0.000515	0.00324	CbGeAlD
Lamivudine—Fatigue—Procarbazine—brain cancer	0.000515	0.00236	CcSEcCtD
Lamivudine—ABCC4—central nervous system—brain cancer	0.000513	0.00322	CbGeAlD
Lamivudine—Malaise—Hydroxyurea—brain cancer	0.000511	0.00234	CcSEcCtD
Lamivudine—Constipation—Procarbazine—brain cancer	0.000511	0.00234	CcSEcCtD
Lamivudine—Pain—Procarbazine—brain cancer	0.000511	0.00234	CcSEcCtD
Lamivudine—Hepatitis—Temozolomide—brain cancer	0.000508	0.00233	CcSEcCtD
Lamivudine—Dysphagia—Etoposide—brain cancer	0.000508	0.00233	CcSEcCtD
Lamivudine—Leukopenia—Hydroxyurea—brain cancer	0.000507	0.00232	CcSEcCtD
Lamivudine—Hypoaesthesia—Temozolomide—brain cancer	0.000506	0.00232	CcSEcCtD
Lamivudine—Pharyngitis—Temozolomide—brain cancer	0.000504	0.00231	CcSEcCtD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000503	0.00498	CbGpPWpGaD
Lamivudine—ABCG2—medulla oblongata—brain cancer	0.000501	0.00314	CbGeAlD
Lamivudine—Connective tissue disorder—Temozolomide—brain cancer	0.000499	0.00229	CcSEcCtD
Lamivudine—Sweating increased—Etoposide—brain cancer	0.000495	0.00227	CcSEcCtD
Lamivudine—ABCC3—brain—brain cancer	0.000493	0.0031	CbGeAlD
Lamivudine—Feeling abnormal—Procarbazine—brain cancer	0.000492	0.00226	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000492	0.00486	CbGpPWpGaD
Lamivudine—Convulsion—Hydroxyurea—brain cancer	0.000491	0.00225	CcSEcCtD
Lamivudine—Gastrointestinal pain—Procarbazine—brain cancer	0.000488	0.00224	CcSEcCtD
Lamivudine—Pancytopenia—Etoposide—brain cancer	0.000482	0.00221	CcSEcCtD
Lamivudine—Erythema multiforme—Temozolomide—brain cancer	0.000481	0.0022	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000479	0.00219	CcSEcCtD
Lamivudine—Discomfort—Hydroxyurea—brain cancer	0.000476	0.00218	CcSEcCtD
Lamivudine—Neutropenia—Etoposide—brain cancer	0.000475	0.00218	CcSEcCtD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000475	0.0047	CbGpPWpGaD
Lamivudine—Urticaria—Procarbazine—brain cancer	0.000474	0.00217	CcSEcCtD
Lamivudine—Abdominal pain—Procarbazine—brain cancer	0.000472	0.00216	CcSEcCtD
Lamivudine—Body temperature increased—Procarbazine—brain cancer	0.000472	0.00216	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000468	0.00463	CbGpPWpGaD
Lamivudine—Alopecia—Carmustine—brain cancer	0.000465	0.00213	CcSEcCtD
Lamivudine—Oedema—Hydroxyurea—brain cancer	0.000462	0.00212	CcSEcCtD
Lamivudine—Infection—Hydroxyurea—brain cancer	0.000459	0.0021	CcSEcCtD
Lamivudine—Immune system disorder—Temozolomide—brain cancer	0.000459	0.0021	CcSEcCtD
Lamivudine—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—brain cancer	0.000458	0.00453	CbGpPWpGaD
Lamivudine—Mediastinal disorder—Temozolomide—brain cancer	0.000458	0.0021	CcSEcCtD
Lamivudine—Malnutrition—Carmustine—brain cancer	0.000458	0.0021	CcSEcCtD
Lamivudine—Erythema—Carmustine—brain cancer	0.000458	0.0021	CcSEcCtD
Lamivudine—ABCG2—midbrain—brain cancer	0.000458	0.00287	CbGeAlD
Lamivudine—Chills—Temozolomide—brain cancer	0.000456	0.00209	CcSEcCtD
Lamivudine—Nervous system disorder—Hydroxyurea—brain cancer	0.000453	0.00208	CcSEcCtD
Lamivudine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000453	0.00207	CcSEcCtD
Lamivudine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000449	0.00206	CcSEcCtD
Lamivudine—Alopecia—Temozolomide—brain cancer	0.000449	0.00206	CcSEcCtD
Lamivudine—Skin disorder—Hydroxyurea—brain cancer	0.000449	0.00206	CcSEcCtD
Lamivudine—ABCG2—spinal cord—brain cancer	0.000446	0.0028	CbGeAlD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—MPL—brain cancer	0.000446	0.00441	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.000446	0.00441	CbGpPWpGaD
Lamivudine—Renal failure—Etoposide—brain cancer	0.000445	0.00204	CcSEcCtD
Lamivudine—Neuropathy peripheral—Etoposide—brain cancer	0.000444	0.00204	CcSEcCtD
Lamivudine—Back pain—Carmustine—brain cancer	0.000443	0.00203	CcSEcCtD
Lamivudine—Malnutrition—Temozolomide—brain cancer	0.000442	0.00203	CcSEcCtD
Lamivudine—Erythema—Temozolomide—brain cancer	0.000442	0.00203	CcSEcCtD
Lamivudine—Jaundice—Etoposide—brain cancer	0.000442	0.00202	CcSEcCtD
Lamivudine—Stomatitis—Etoposide—brain cancer	0.000442	0.00202	CcSEcCtD
Lamivudine—Anorexia—Hydroxyurea—brain cancer	0.000441	0.00202	CcSEcCtD
Lamivudine—Hypersensitivity—Procarbazine—brain cancer	0.00044	0.00202	CcSEcCtD
Lamivudine—SLC22A1—brain—brain cancer	0.000439	0.00276	CbGeAlD
Lamivudine—Dysgeusia—Temozolomide—brain cancer	0.000433	0.00199	CcSEcCtD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—SIRT1—brain cancer	0.000432	0.00428	CbGpPWpGaD
Lamivudine—Tremor—Carmustine—brain cancer	0.000429	0.00197	CcSEcCtD
Lamivudine—Asthenia—Procarbazine—brain cancer	0.000428	0.00196	CcSEcCtD
Lamivudine—Hepatobiliary disease—Etoposide—brain cancer	0.000428	0.00196	CcSEcCtD
Lamivudine—Back pain—Temozolomide—brain cancer	0.000428	0.00196	CcSEcCtD
Lamivudine—ABCC1—cerebellum—brain cancer	0.000428	0.00269	CbGeAlD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000423	0.00419	CbGpPWpGaD
Lamivudine—Anaemia—Carmustine—brain cancer	0.000423	0.00194	CcSEcCtD
Lamivudine—Agranulocytosis—Etoposide—brain cancer	0.000423	0.00194	CcSEcCtD
Lamivudine—Pruritus—Procarbazine—brain cancer	0.000422	0.00194	CcSEcCtD
Lamivudine—SLC22A3—brain—brain cancer	0.00042	0.00264	CbGeAlD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000415	0.0041	CbGpPWpGaD
Lamivudine—Tremor—Temozolomide—brain cancer	0.000414	0.0019	CcSEcCtD
Lamivudine—Dyspnoea—Hydroxyurea—brain cancer	0.000412	0.00189	CcSEcCtD
Lamivudine—Somnolence—Hydroxyurea—brain cancer	0.000411	0.00188	CcSEcCtD
Lamivudine—Ill-defined disorder—Temozolomide—brain cancer	0.00041	0.00188	CcSEcCtD
Lamivudine—Leukopenia—Carmustine—brain cancer	0.00041	0.00188	CcSEcCtD
Lamivudine—Anaemia—Temozolomide—brain cancer	0.000409	0.00187	CcSEcCtD
Lamivudine—Diarrhoea—Procarbazine—brain cancer	0.000409	0.00187	CcSEcCtD
Lamivudine—ABCC4—brain—brain cancer	0.000407	0.00256	CbGeAlD
Lamivudine—Dyspepsia—Hydroxyurea—brain cancer	0.000407	0.00186	CcSEcCtD
Lamivudine—Hypoaesthesia—Etoposide—brain cancer	0.000405	0.00185	CcSEcCtD
Lamivudine—Angioedema—Temozolomide—brain cancer	0.000404	0.00185	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000404	0.00399	CbGpPWpGaD
Lamivudine—Decreased appetite—Hydroxyurea—brain cancer	0.000402	0.00184	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000399	0.00183	CcSEcCtD
Lamivudine—Malaise—Temozolomide—brain cancer	0.000399	0.00183	CcSEcCtD
Lamivudine—Fatigue—Hydroxyurea—brain cancer	0.000398	0.00183	CcSEcCtD
Lamivudine—PGK1—Disease—HES5—brain cancer	0.000398	0.00394	CbGpPWpGaD
Lamivudine—Vertigo—Temozolomide—brain cancer	0.000397	0.00182	CcSEcCtD
Lamivudine—Convulsion—Carmustine—brain cancer	0.000397	0.00182	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000396	0.00392	CbGpPWpGaD
Lamivudine—Leukopenia—Temozolomide—brain cancer	0.000396	0.00182	CcSEcCtD
Lamivudine—Constipation—Hydroxyurea—brain cancer	0.000395	0.00181	CcSEcCtD
Lamivudine—Pain—Hydroxyurea—brain cancer	0.000395	0.00181	CcSEcCtD
Lamivudine—Dizziness—Procarbazine—brain cancer	0.000395	0.00181	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000391	0.00387	CbGpPWpGaD
Lamivudine—Chest pain—Carmustine—brain cancer	0.00039	0.00179	CcSEcCtD
Lamivudine—Myalgia—Carmustine—brain cancer	0.00039	0.00179	CcSEcCtD
Lamivudine—Anxiety—Carmustine—brain cancer	0.000388	0.00178	CcSEcCtD
Lamivudine—Cough—Temozolomide—brain cancer	0.000386	0.00177	CcSEcCtD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000385	0.00381	CbGpPWpGaD
Lamivudine—Erythema multiforme—Etoposide—brain cancer	0.000384	0.00176	CcSEcCtD
Lamivudine—Convulsion—Temozolomide—brain cancer	0.000383	0.00176	CcSEcCtD
Lamivudine—Feeling abnormal—Hydroxyurea—brain cancer	0.000381	0.00175	CcSEcCtD
Lamivudine—Vomiting—Procarbazine—brain cancer	0.00038	0.00174	CcSEcCtD
Lamivudine—Confusional state—Carmustine—brain cancer	0.000377	0.00173	CcSEcCtD
Lamivudine—Myalgia—Temozolomide—brain cancer	0.000377	0.00173	CcSEcCtD
Lamivudine—Arthralgia—Temozolomide—brain cancer	0.000377	0.00173	CcSEcCtD
Lamivudine—Rash—Procarbazine—brain cancer	0.000377	0.00173	CcSEcCtD
Lamivudine—CMPK1—Metabolism—CYP2C9—brain cancer	0.000376	0.00372	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—CYP2C9—brain cancer	0.000376	0.00372	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—CYP2C9—brain cancer	0.000376	0.00372	CbGpPWpGaD
Lamivudine—Dermatitis—Procarbazine—brain cancer	0.000376	0.00172	CcSEcCtD
Lamivudine—Anxiety—Temozolomide—brain cancer	0.000375	0.00172	CcSEcCtD
Lamivudine—Headache—Procarbazine—brain cancer	0.000374	0.00171	CcSEcCtD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000374	0.00171	CcSEcCtD
Lamivudine—Oedema—Carmustine—brain cancer	0.000374	0.00171	CcSEcCtD
Lamivudine—Discomfort—Temozolomide—brain cancer	0.000372	0.00171	CcSEcCtD
Lamivudine—Infection—Carmustine—brain cancer	0.000371	0.0017	CcSEcCtD
Lamivudine—Dry mouth—Temozolomide—brain cancer	0.000368	0.00169	CcSEcCtD
Lamivudine—Immune system disorder—Etoposide—brain cancer	0.000367	0.00168	CcSEcCtD
Lamivudine—Mediastinal disorder—Etoposide—brain cancer	0.000366	0.00168	CcSEcCtD
Lamivudine—Thrombocytopenia—Carmustine—brain cancer	0.000366	0.00168	CcSEcCtD
Lamivudine—Body temperature increased—Hydroxyurea—brain cancer	0.000365	0.00167	CcSEcCtD
Lamivudine—Chills—Etoposide—brain cancer	0.000365	0.00167	CcSEcCtD
Lamivudine—Confusional state—Temozolomide—brain cancer	0.000364	0.00167	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000364	0.0036	CbGpPWpGaD
Lamivudine—Anaphylactic shock—Temozolomide—brain cancer	0.000361	0.00166	CcSEcCtD
Lamivudine—Oedema—Temozolomide—brain cancer	0.000361	0.00166	CcSEcCtD
Lamivudine—Alopecia—Etoposide—brain cancer	0.000359	0.00165	CcSEcCtD
Lamivudine—Infection—Temozolomide—brain cancer	0.000359	0.00164	CcSEcCtD
Lamivudine—Anorexia—Carmustine—brain cancer	0.000356	0.00163	CcSEcCtD
Lamivudine—Nausea—Procarbazine—brain cancer	0.000355	0.00163	CcSEcCtD
Lamivudine—Nervous system disorder—Temozolomide—brain cancer	0.000354	0.00162	CcSEcCtD
Lamivudine—ABCG2—cerebellum—brain cancer	0.000354	0.00222	CbGeAlD
Lamivudine—Thrombocytopenia—Temozolomide—brain cancer	0.000354	0.00162	CcSEcCtD
Lamivudine—Skin disorder—Temozolomide—brain cancer	0.000351	0.00161	CcSEcCtD
Lamivudine—Hypotension—Carmustine—brain cancer	0.000349	0.0016	CcSEcCtD
Lamivudine—Hyperhidrosis—Temozolomide—brain cancer	0.000349	0.0016	CcSEcCtD
Lamivudine—ABCC1—brain—brain cancer	0.000347	0.00218	CbGeAlD
Lamivudine—Dysgeusia—Etoposide—brain cancer	0.000347	0.00159	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000346	0.00343	CbGpPWpGaD
Lamivudine—Anorexia—Temozolomide—brain cancer	0.000344	0.00158	CcSEcCtD
Lamivudine—Back pain—Etoposide—brain cancer	0.000342	0.00157	CcSEcCtD
Lamivudine—NME2—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000341	0.00337	CbGpPWpGaD
Lamivudine—Hypersensitivity—Hydroxyurea—brain cancer	0.000341	0.00156	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Carmustine—brain cancer	0.00034	0.00156	CcSEcCtD
Lamivudine—Muscle spasms—Etoposide—brain cancer	0.00034	0.00156	CcSEcCtD
Lamivudine—Insomnia—Carmustine—brain cancer	0.000338	0.00155	CcSEcCtD
Lamivudine—Paraesthesia—Carmustine—brain cancer	0.000335	0.00154	CcSEcCtD
Lamivudine—ABCC1—S1P1 pathway—VEGFA—brain cancer	0.000333	0.0033	CbGpPWpGaD
Lamivudine—Dyspnoea—Carmustine—brain cancer	0.000333	0.00153	CcSEcCtD
Lamivudine—Somnolence—Carmustine—brain cancer	0.000332	0.00152	CcSEcCtD
Lamivudine—Asthenia—Hydroxyurea—brain cancer	0.000332	0.00152	CcSEcCtD
Lamivudine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000329	0.00151	CcSEcCtD
Lamivudine—Ill-defined disorder—Etoposide—brain cancer	0.000328	0.00151	CcSEcCtD
Lamivudine—Anaemia—Etoposide—brain cancer	0.000327	0.0015	CcSEcCtD
Lamivudine—Insomnia—Temozolomide—brain cancer	0.000327	0.0015	CcSEcCtD
Lamivudine—Decreased appetite—Carmustine—brain cancer	0.000325	0.00149	CcSEcCtD
Lamivudine—Paraesthesia—Temozolomide—brain cancer	0.000324	0.00149	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Carmustine—brain cancer	0.000323	0.00148	CcSEcCtD
Lamivudine—Dyspnoea—Temozolomide—brain cancer	0.000322	0.00148	CcSEcCtD
Lamivudine—Somnolence—Temozolomide—brain cancer	0.000321	0.00147	CcSEcCtD
Lamivudine—PCYT2—Metabolism—BSG—brain cancer	0.00032	0.00316	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—BSG—brain cancer	0.00032	0.00316	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—BSG—brain cancer	0.00032	0.00316	CbGpPWpGaD
Lamivudine—Pain—Carmustine—brain cancer	0.000319	0.00146	CcSEcCtD
Lamivudine—Constipation—Carmustine—brain cancer	0.000319	0.00146	CcSEcCtD
Lamivudine—Malaise—Etoposide—brain cancer	0.000319	0.00146	CcSEcCtD
Lamivudine—Vertigo—Etoposide—brain cancer	0.000318	0.00146	CcSEcCtD
Lamivudine—Dyspepsia—Temozolomide—brain cancer	0.000318	0.00146	CcSEcCtD
Lamivudine—Leukopenia—Etoposide—brain cancer	0.000317	0.00145	CcSEcCtD
Lamivudine—Diarrhoea—Hydroxyurea—brain cancer	0.000316	0.00145	CcSEcCtD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—MYC—brain cancer	0.000314	0.00311	CbGpPWpGaD
Lamivudine—ABCB1—telencephalon—brain cancer	0.000314	0.00197	CbGeAlD
Lamivudine—Decreased appetite—Temozolomide—brain cancer	0.000314	0.00144	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000312	0.00143	CcSEcCtD
Lamivudine—Fatigue—Temozolomide—brain cancer	0.000311	0.00143	CcSEcCtD
Lamivudine—Loss of consciousness—Etoposide—brain cancer	0.000311	0.00143	CcSEcCtD
Lamivudine—Cough—Etoposide—brain cancer	0.000309	0.00142	CcSEcCtD
Lamivudine—Constipation—Temozolomide—brain cancer	0.000309	0.00142	CcSEcCtD
Lamivudine—Pain—Temozolomide—brain cancer	0.000309	0.00142	CcSEcCtD
Lamivudine—Feeling abnormal—Carmustine—brain cancer	0.000308	0.00141	CcSEcCtD
Lamivudine—PGK1—Metabolism—CYP2C9—brain cancer	0.000307	0.00303	CbGpPWpGaD
Lamivudine—Convulsion—Etoposide—brain cancer	0.000307	0.00141	CcSEcCtD
Lamivudine—Dizziness—Hydroxyurea—brain cancer	0.000306	0.0014	CcSEcCtD
Lamivudine—Gastrointestinal pain—Carmustine—brain cancer	0.000306	0.0014	CcSEcCtD
Lamivudine—Chest pain—Etoposide—brain cancer	0.000301	0.00138	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.0003	0.00296	CbGpPWpGaD
Lamivudine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000299	0.00137	CcSEcCtD
Lamivudine—ABCC4—Ectoderm Differentiation—SHH—brain cancer	0.000298	0.00295	CbGpPWpGaD
Lamivudine—Discomfort—Etoposide—brain cancer	0.000298	0.00136	CcSEcCtD
Lamivudine—Feeling abnormal—Temozolomide—brain cancer	0.000298	0.00136	CcSEcCtD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.000296	0.00293	CbGpPWpGaD
Lamivudine—Abdominal pain—Carmustine—brain cancer	0.000295	0.00135	CcSEcCtD
Lamivudine—Body temperature increased—Carmustine—brain cancer	0.000295	0.00135	CcSEcCtD
Lamivudine—Gastrointestinal pain—Temozolomide—brain cancer	0.000295	0.00135	CcSEcCtD
Lamivudine—Vomiting—Hydroxyurea—brain cancer	0.000294	0.00135	CcSEcCtD
Lamivudine—Rash—Hydroxyurea—brain cancer	0.000291	0.00134	CcSEcCtD
Lamivudine—Confusional state—Etoposide—brain cancer	0.000291	0.00134	CcSEcCtD
Lamivudine—Dermatitis—Hydroxyurea—brain cancer	0.000291	0.00133	CcSEcCtD
Lamivudine—Headache—Hydroxyurea—brain cancer	0.00029	0.00133	CcSEcCtD
Lamivudine—Anaphylactic shock—Etoposide—brain cancer	0.000289	0.00132	CcSEcCtD
Lamivudine—ABCG2—brain—brain cancer	0.000287	0.00181	CbGeAlD
Lamivudine—Infection—Etoposide—brain cancer	0.000287	0.00132	CcSEcCtD
Lamivudine—Urticaria—Temozolomide—brain cancer	0.000287	0.00131	CcSEcCtD
Lamivudine—Abdominal pain—Temozolomide—brain cancer	0.000285	0.00131	CcSEcCtD
Lamivudine—Body temperature increased—Temozolomide—brain cancer	0.000285	0.00131	CcSEcCtD
Lamivudine—PCYT1A—Metabolism—CYP2C9—brain cancer	0.000285	0.00282	CbGpPWpGaD
Lamivudine—Thrombocytopenia—Etoposide—brain cancer	0.000283	0.0013	CcSEcCtD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000282	0.00279	CbGpPWpGaD
Lamivudine—Skin disorder—Etoposide—brain cancer	0.000281	0.00129	CcSEcCtD
Lamivudine—Hyperhidrosis—Etoposide—brain cancer	0.000279	0.00128	CcSEcCtD
Lamivudine—Anorexia—Etoposide—brain cancer	0.000275	0.00126	CcSEcCtD
Lamivudine—Hypersensitivity—Carmustine—brain cancer	0.000275	0.00126	CcSEcCtD
Lamivudine—PCYT2—Metabolism—IDH1—brain cancer	0.000275	0.00272	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—IDH1—brain cancer	0.000275	0.00272	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—IDH1—brain cancer	0.000275	0.00272	CbGpPWpGaD
Lamivudine—Nausea—Hydroxyurea—brain cancer	0.000275	0.00126	CcSEcCtD
Lamivudine—Hypotension—Etoposide—brain cancer	0.00027	0.00124	CcSEcCtD
Lamivudine—Asthenia—Carmustine—brain cancer	0.000268	0.00123	CcSEcCtD
Lamivudine—PGK1—Disease—IDH1—brain cancer	0.000268	0.00265	CbGpPWpGaD
Lamivudine—Hypersensitivity—Temozolomide—brain cancer	0.000266	0.00122	CcSEcCtD
Lamivudine—ABCB1—gonad—brain cancer	0.000262	0.00165	CbGeAlD
Lamivudine—PGK1—Metabolism—BSG—brain cancer	0.000261	0.00258	CbGpPWpGaD
Lamivudine—NME2—Metabolism—CYP2C9—brain cancer	0.000261	0.00258	CbGpPWpGaD
Lamivudine—Paraesthesia—Etoposide—brain cancer	0.000259	0.00119	CcSEcCtD
Lamivudine—Asthenia—Temozolomide—brain cancer	0.000259	0.00119	CcSEcCtD
Lamivudine—NME1—Validated targets of C-MYC transcriptional activation—TP53—brain cancer	0.000258	0.00255	CbGpPWpGaD
Lamivudine—Dyspnoea—Etoposide—brain cancer	0.000258	0.00118	CcSEcCtD
Lamivudine—Somnolence—Etoposide—brain cancer	0.000257	0.00118	CcSEcCtD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000257	0.00254	CbGpPWpGaD
Lamivudine—ABCB1—pituitary gland—brain cancer	0.000256	0.00161	CbGeAlD
Lamivudine—Diarrhoea—Carmustine—brain cancer	0.000256	0.00117	CcSEcCtD
Lamivudine—Pruritus—Temozolomide—brain cancer	0.000255	0.00117	CcSEcCtD
Lamivudine—PGK1—Disease—HEY1—brain cancer	0.000254	0.00251	CbGpPWpGaD
Lamivudine—Decreased appetite—Etoposide—brain cancer	0.000251	0.00115	CcSEcCtD
Lamivudine—Gastrointestinal disorder—Etoposide—brain cancer	0.000249	0.00114	CcSEcCtD
Lamivudine—Fatigue—Etoposide—brain cancer	0.000249	0.00114	CcSEcCtD
Lamivudine—PGK1—Disease—DLL1—brain cancer	0.000249	0.00246	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000249	0.00246	CbGpPWpGaD
Lamivudine—Dizziness—Carmustine—brain cancer	0.000247	0.00113	CcSEcCtD
Lamivudine—Pain—Etoposide—brain cancer	0.000247	0.00113	CcSEcCtD
Lamivudine—Constipation—Etoposide—brain cancer	0.000247	0.00113	CcSEcCtD
Lamivudine—Diarrhoea—Temozolomide—brain cancer	0.000247	0.00113	CcSEcCtD
Lamivudine—ABCB1—medulla oblongata—brain cancer	0.000247	0.00155	CbGeAlD
Lamivudine—PCYT1A—Metabolism—BSG—brain cancer	0.000243	0.0024	CbGpPWpGaD
Lamivudine—Dizziness—Temozolomide—brain cancer	0.000239	0.00109	CcSEcCtD
Lamivudine—Feeling abnormal—Etoposide—brain cancer	0.000238	0.00109	CcSEcCtD
Lamivudine—Vomiting—Carmustine—brain cancer	0.000238	0.00109	CcSEcCtD
Lamivudine—Gastrointestinal pain—Etoposide—brain cancer	0.000236	0.00108	CcSEcCtD
Lamivudine—Rash—Carmustine—brain cancer	0.000236	0.00108	CcSEcCtD
Lamivudine—Dermatitis—Carmustine—brain cancer	0.000235	0.00108	CcSEcCtD
Lamivudine—Headache—Carmustine—brain cancer	0.000234	0.00107	CcSEcCtD
Lamivudine—ABCC4—Hemostasis—MPL—brain cancer	0.00023	0.00227	CbGpPWpGaD
Lamivudine—Vomiting—Temozolomide—brain cancer	0.00023	0.00105	CcSEcCtD
Lamivudine—Urticaria—Etoposide—brain cancer	0.00023	0.00105	CcSEcCtD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.000229	0.00226	CbGpPWpGaD
Lamivudine—Body temperature increased—Etoposide—brain cancer	0.000228	0.00105	CcSEcCtD
Lamivudine—Abdominal pain—Etoposide—brain cancer	0.000228	0.00105	CcSEcCtD
Lamivudine—Rash—Temozolomide—brain cancer	0.000228	0.00104	CcSEcCtD
Lamivudine—Dermatitis—Temozolomide—brain cancer	0.000227	0.00104	CcSEcCtD
Lamivudine—Headache—Temozolomide—brain cancer	0.000226	0.00104	CcSEcCtD
Lamivudine—ABCB1—midbrain—brain cancer	0.000226	0.00142	CbGeAlD
Lamivudine—PGK1—Metabolism—IDH1—brain cancer	0.000224	0.00222	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000224	0.00222	CbGpPWpGaD
Lamivudine—Nausea—Carmustine—brain cancer	0.000222	0.00102	CcSEcCtD
Lamivudine—NME2—Metabolism—BSG—brain cancer	0.000222	0.00219	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000221	0.00218	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—S100A10—brain cancer	0.00022	0.00218	CbGpPWpGaD
Lamivudine—ABCB1—spinal cord—brain cancer	0.00022	0.00138	CbGeAlD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000219	0.00216	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—ENO2—brain cancer	0.000218	0.00215	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—ENO2—brain cancer	0.000218	0.00215	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—ENO2—brain cancer	0.000218	0.00215	CbGpPWpGaD
Lamivudine—Nausea—Temozolomide—brain cancer	0.000214	0.000983	CcSEcCtD
Lamivudine—Hypersensitivity—Etoposide—brain cancer	0.000213	0.000976	CcSEcCtD
Lamivudine—PGK1—Disease—SHH—brain cancer	0.000212	0.00209	CbGpPWpGaD
Lamivudine—PGK1—Disease—ENO2—brain cancer	0.000212	0.00209	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—IDH1—brain cancer	0.000209	0.00206	CbGpPWpGaD
Lamivudine—Asthenia—Etoposide—brain cancer	0.000207	0.00095	CcSEcCtD
Lamivudine—ABCC3—Fluoropyrimidine Activity—TP53—brain cancer	0.000207	0.00204	CbGpPWpGaD
Lamivudine—Pruritus—Etoposide—brain cancer	0.000204	0.000937	CcSEcCtD
Lamivudine—ABCC3—Transmembrane transport of small molecules—S100A10—brain cancer	0.000203	0.00201	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.0002	0.00197	CbGpPWpGaD
Lamivudine—ABCB1—endocrine gland—brain cancer	0.000198	0.00124	CbGeAlD
Lamivudine—NME1—Metabolism—CYP2C9—brain cancer	0.000198	0.00196	CbGpPWpGaD
Lamivudine—Diarrhoea—Etoposide—brain cancer	0.000198	0.000906	CcSEcCtD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—TRPC6—brain cancer	0.000197	0.00195	CbGpPWpGaD
Lamivudine—ABCB1—head—brain cancer	0.000196	0.00123	CbGeAlD
Lamivudine—ABCC4—Fluoropyrimidine Activity—TP53—brain cancer	0.000194	0.00192	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000193	0.00191	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000192	0.00189	CbGpPWpGaD
Lamivudine—Dizziness—Etoposide—brain cancer	0.000191	0.000876	CcSEcCtD
Lamivudine—NME2—Metabolism—IDH1—brain cancer	0.000191	0.00189	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—S100A10—brain cancer	0.000191	0.00189	CbGpPWpGaD
Lamivudine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—brain cancer	0.000184	0.00182	CbGpPWpGaD
Lamivudine—Vomiting—Etoposide—brain cancer	0.000184	0.000842	CcSEcCtD
Lamivudine—Rash—Etoposide—brain cancer	0.000182	0.000835	CcSEcCtD
Lamivudine—Dermatitis—Etoposide—brain cancer	0.000182	0.000834	CcSEcCtD
Lamivudine—Headache—Etoposide—brain cancer	0.000181	0.00083	CcSEcCtD
Lamivudine—ABCB1—central nervous system—brain cancer	0.000179	0.00112	CbGeAlD
Lamivudine—PGK1—Metabolism—ENO2—brain cancer	0.000177	0.00175	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000177	0.00175	CbGpPWpGaD
Lamivudine—ABCB1—cerebellum—brain cancer	0.000175	0.0011	CbGeAlD
Lamivudine—Nausea—Etoposide—brain cancer	0.000172	0.000787	CcSEcCtD
Lamivudine—PCYT1A—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.00017	0.00168	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000169	0.00167	CbGpPWpGaD
Lamivudine—NME1—Metabolism—BSG—brain cancer	0.000168	0.00166	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000166	0.00164	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—ENO2—brain cancer	0.000165	0.00163	CbGpPWpGaD
Lamivudine—DCK—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000164	0.00162	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000161	0.00159	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	0.00016	0.00158	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000159	0.00157	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—BSG—brain cancer	0.000155	0.00153	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	0.000155	0.00153	CbGpPWpGaD
Lamivudine—PGK1—Disease—VAV1—brain cancer	0.000153	0.00151	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	0.000152	0.0015	CbGpPWpGaD
Lamivudine—NME2—Metabolism—ENO2—brain cancer	0.000151	0.00149	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VAV1—brain cancer	0.000148	0.00146	CbGpPWpGaD
Lamivudine—NME1—Metabolism—IDH1—brain cancer	0.000145	0.00143	CbGpPWpGaD
Lamivudine—ABCG2—Fluoropyrimidine Activity—TP53—brain cancer	0.000142	0.00141	CbGpPWpGaD
Lamivudine—ABCB1—brain—brain cancer	0.000142	0.000891	CbGeAlD
Lamivudine—ABCG2—Transmembrane transport of small molecules—S100A10—brain cancer	0.00014	0.00138	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000139	0.00137	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—S100A10—brain cancer	0.000138	0.00137	CbGpPWpGaD
Lamivudine—DCK—Metabolism—CYP2C9—brain cancer	0.000136	0.00134	CbGpPWpGaD
Lamivudine—PGK1—Disease—HES1—brain cancer	0.000132	0.0013	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000129	0.00128	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000129	0.00128	CbGpPWpGaD
Lamivudine—NME1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	0.000127	0.00126	CbGpPWpGaD
Lamivudine—ABCC4—Platelet degranulation—VEGFA—brain cancer	0.000127	0.00125	CbGpPWpGaD
Lamivudine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	0.000126	0.00125	CbGpPWpGaD
Lamivudine—PGK1—Disease—PDGFRA—brain cancer	0.000125	0.00124	CbGpPWpGaD
Lamivudine—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	0.000121	0.00119	CbGpPWpGaD
Lamivudine—DCK—Metabolism—BSG—brain cancer	0.000115	0.00114	CbGpPWpGaD
Lamivudine—NME1—Metabolism—ENO2—brain cancer	0.000114	0.00113	CbGpPWpGaD
Lamivudine—PGK1—Disease—IRS2—brain cancer	0.00011	0.00109	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—PDGFRA—brain cancer	0.000109	0.00108	CbGpPWpGaD
Lamivudine—ABCC1—Disease—DTX2—brain cancer	0.000109	0.00108	CbGpPWpGaD
Lamivudine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—brain cancer	0.000108	0.00107	CbGpPWpGaD
Lamivudine—SLC22A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000102	0.00101	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TRPC6—brain cancer	0.000102	0.00101	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000101	0.001	CbGpPWpGaD
Lamivudine—PCYT2—Metabolism—PIK3CG—brain cancer	9.98e-05	0.000987	CbGpPWpGaD
Lamivudine—CMPK1—Metabolism—PIK3CG—brain cancer	9.98e-05	0.000987	CbGpPWpGaD
Lamivudine—NT5C—Metabolism—PIK3CG—brain cancer	9.98e-05	0.000987	CbGpPWpGaD
Lamivudine—DCK—Metabolism—IDH1—brain cancer	9.92e-05	0.000981	CbGpPWpGaD
Lamivudine—PGK1—Disease—APC—brain cancer	9.72e-05	0.000961	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	9.39e-05	0.000928	CbGpPWpGaD
Lamivudine—ABCC3—Transmembrane transport of small molecules—TRPC6—brain cancer	9.37e-05	0.000926	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—CTNNB1—brain cancer	9.3e-05	0.000919	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	9.12e-05	0.000902	CbGpPWpGaD
Lamivudine—ABCC4—Transmembrane transport of small molecules—TRPC6—brain cancer	8.81e-05	0.000871	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	8.65e-05	0.000855	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—CYP2C9—brain cancer	8.56e-05	0.000847	CbGpPWpGaD
Lamivudine—PGK1—Metabolism—PIK3CG—brain cancer	8.14e-05	0.000805	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES5—brain cancer	8e-05	0.000791	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—CYP2C9—brain cancer	7.87e-05	0.000778	CbGpPWpGaD
Lamivudine—DCK—Metabolism—ENO2—brain cancer	7.84e-05	0.000775	CbGpPWpGaD
Lamivudine—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	7.67e-05	0.000758	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VAV1—brain cancer	7.62e-05	0.000754	CbGpPWpGaD
Lamivudine—PCYT1A—Metabolism—PIK3CG—brain cancer	7.56e-05	0.000748	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	7.56e-05	0.000748	CbGpPWpGaD
Lamivudine—PGK1—Disease—ERBB2—brain cancer	7.54e-05	0.000746	CbGpPWpGaD
Lamivudine—ABCC4—Ectoderm Differentiation—MYC—brain cancer	7.53e-05	0.000745	CbGpPWpGaD
Lamivudine—ABCC2—Transmembrane transport of small molecules—TRPC6—brain cancer	7.43e-05	0.000734	CbGpPWpGaD
Lamivudine—ABCC1—Transmembrane transport of small molecules—TRPC6—brain cancer	7.34e-05	0.000726	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	7.3e-05	0.000722	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—BSG—brain cancer	7.28e-05	0.00072	CbGpPWpGaD
Lamivudine—NME2—Metabolism—PIK3CG—brain cancer	6.92e-05	0.000684	CbGpPWpGaD
Lamivudine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	6.84e-05	0.000676	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—BSG—brain cancer	6.69e-05	0.000662	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—IL2—brain cancer	6.61e-05	0.000653	CbGpPWpGaD
Lamivudine—PGK1—Disease—CTNNB1—brain cancer	6.6e-05	0.000653	CbGpPWpGaD
Lamivudine—ABCG2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.46e-05	0.000639	CbGpPWpGaD
Lamivudine—SLC22A2—Transmembrane transport of small molecules—TRPC6—brain cancer	6.39e-05	0.000632	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—IDH1—brain cancer	6.26e-05	0.000619	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—CYP2C9—brain cancer	6.17e-05	0.00061	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	5.99e-05	0.000593	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—IL2—brain cancer	5.97e-05	0.00059	CbGpPWpGaD
Lamivudine—SLC22A1—Transmembrane transport of small molecules—TRPC6—brain cancer	5.96e-05	0.000589	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	5.88e-05	0.000581	CbGpPWpGaD
Lamivudine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	5.86e-05	0.000579	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	5.8e-05	0.000574	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—IDH1—brain cancer	5.76e-05	0.000569	CbGpPWpGaD
Lamivudine—PGK1—Disease—STAT3—brain cancer	5.75e-05	0.000569	CbGpPWpGaD
Lamivudine—ABCC4—Platelet activation, signaling and aggregation—VEGFA—brain cancer	5.62e-05	0.000555	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—CYP2C9—brain cancer	5.43e-05	0.000537	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	5.4e-05	0.000534	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IDH1—brain cancer	5.39e-05	0.000533	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—CYP2C9—brain cancer	5.37e-05	0.000531	CbGpPWpGaD
Lamivudine—PGK1—Disease—MYC—brain cancer	5.35e-05	0.000529	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—BSG—brain cancer	5.25e-05	0.000519	CbGpPWpGaD
Lamivudine—NME1—Metabolism—PIK3CG—brain cancer	5.24e-05	0.000518	CbGpPWpGaD
Lamivudine—PGK1—Disease—EGFR—brain cancer	5.23e-05	0.000517	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	5.14e-05	0.000508	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HEY1—brain cancer	5.11e-05	0.000505	CbGpPWpGaD
Lamivudine—ABCB1—Allograft Rejection—VEGFA—brain cancer	5.07e-05	0.000501	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—CYP2C9—brain cancer	5.01e-05	0.000495	CbGpPWpGaD
Lamivudine—ABCC1—Disease—DLL1—brain cancer	5.01e-05	0.000495	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—ENO2—brain cancer	4.95e-05	0.000489	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—PIK3CG—brain cancer	4.84e-05	0.000479	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.69e-05	0.000463	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—BSG—brain cancer	4.62e-05	0.000456	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—BSG—brain cancer	4.57e-05	0.000452	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—ENO2—brain cancer	4.55e-05	0.00045	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—IDH1—brain cancer	4.51e-05	0.000446	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	4.44e-05	0.000439	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—BSG—brain cancer	4.26e-05	0.000421	CbGpPWpGaD
Lamivudine—ABCC1—Disease—SHH—brain cancer	4.26e-05	0.000421	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ENO2—brain cancer	4.26e-05	0.000421	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	4.18e-05	0.000414	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—IDH1—brain cancer	3.97e-05	0.000392	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—IDH1—brain cancer	3.93e-05	0.000388	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.67e-05	0.000363	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—IDH1—brain cancer	3.66e-05	0.000362	CbGpPWpGaD
Lamivudine—DCK—Metabolism—PIK3CG—brain cancer	3.6e-05	0.000356	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—ENO2—brain cancer	3.57e-05	0.000353	CbGpPWpGaD
Lamivudine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	3.49e-05	0.000345	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—IL2—brain cancer	3.41e-05	0.000337	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	3.25e-05	0.000321	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—ENO2—brain cancer	3.14e-05	0.00031	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—ENO2—brain cancer	3.1e-05	0.000307	CbGpPWpGaD
Lamivudine—ABCC1—Disease—VAV1—brain cancer	3.08e-05	0.000304	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—CYP2C9—brain cancer	2.93e-05	0.00029	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—VEGFA—brain cancer	2.89e-05	0.000286	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—ENO2—brain cancer	2.89e-05	0.000286	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.87e-05	0.000284	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.84e-05	0.000281	CbGpPWpGaD
Lamivudine—ABCC1—Disease—HES1—brain cancer	2.65e-05	0.000262	CbGpPWpGaD
Lamivudine—ABCC1—Disease—PDGFRA—brain cancer	2.52e-05	0.000249	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.5e-05	0.000247	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—BSG—brain cancer	2.5e-05	0.000247	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.3e-05	0.000228	CbGpPWpGaD
Lamivudine—SLC22A3—Metabolism—PIK3CG—brain cancer	2.27e-05	0.000225	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	2.25e-05	0.000223	CbGpPWpGaD
Lamivudine—ABCC1—Disease—IRS2—brain cancer	2.21e-05	0.000219	CbGpPWpGaD
Lamivudine—ABCC4—Hemostasis—TP53—brain cancer	2.19e-05	0.000216	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—IDH1—brain cancer	2.15e-05	0.000212	CbGpPWpGaD
Lamivudine—ABCC3—Metabolism—PIK3CG—brain cancer	2.09e-05	0.000206	CbGpPWpGaD
Lamivudine—ABCC1—Disease—APC—brain cancer	1.95e-05	0.000193	CbGpPWpGaD
Lamivudine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.89e-05	0.000187	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—ENO2—brain cancer	1.7e-05	0.000168	CbGpPWpGaD
Lamivudine—ABCC1—Metabolism—PIK3CG—brain cancer	1.64e-05	0.000162	CbGpPWpGaD
Lamivudine—ABCC1—Disease—ERBB2—brain cancer	1.52e-05	0.00015	CbGpPWpGaD
Lamivudine—ABCG2—Metabolism—PIK3CG—brain cancer	1.44e-05	0.000142	CbGpPWpGaD
Lamivudine—SLC22A2—Metabolism—PIK3CG—brain cancer	1.42e-05	0.000141	CbGpPWpGaD
Lamivudine—SLC22A1—Metabolism—PIK3CG—brain cancer	1.33e-05	0.000131	CbGpPWpGaD
Lamivudine—ABCC1—Disease—CTNNB1—brain cancer	1.33e-05	0.000131	CbGpPWpGaD
Lamivudine—ABCC1—Disease—STAT3—brain cancer	1.16e-05	0.000114	CbGpPWpGaD
Lamivudine—ABCC1—Disease—MYC—brain cancer	1.07e-05	0.000106	CbGpPWpGaD
Lamivudine—ABCC1—Disease—EGFR—brain cancer	1.05e-05	0.000104	CbGpPWpGaD
Lamivudine—ABCB1—Metabolism—PIK3CG—brain cancer	7.78e-06	7.69e-05	CbGpPWpGaD
